Delivery Order SPE2DB22D2206-SPE2DB24FJW37

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,047.03 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025, with a completion date of February 25, 2025. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $9,058.66, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of March 5, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,645.62 and was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 24, 2024. The contract was not set aside for any specific business category....
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
The federal contract award summarized here is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,374.92 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 16, 2024. The contract has an ultimate completion date of October 17, 2024 and is a delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor,...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $18,395.16, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 29, 2024. The contract is not designated as a set-aside and appears to be part of a larger...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,150.31 and a completion date of October 25, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,692.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 28, 2024 and was awarded on February 27, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency, a defense agency. The $10,905.44 firm fixed price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 19, 2024, with a ceiling value of $1,228.50 and a completion date of December 20, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between AmerisourceBergen and the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJW37
    Delivery Order

This federal contract award is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,001.38, is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed-price pricing type and an ultimate completion date of August 20, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and federal healthcare providers nationwide.

Generated 11/18/24, 9:44 AM